Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
BlackRock, Inc. reported a 5.10% stake in Ars Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.10% stake in Ars Pharmaceuticals, Inc., 5,013,000 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 5,013,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 5,013,000 |
Source
Related
- Ars Pharmaceuticals, Inc.
- BlackRock, Inc.
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G/A · Millennium Management LLC · Mar 31, 2026